Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS
· Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025
RAJAF Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 0.04 | 0.02 | 0.01 | 0.1 | 0 |
| Cash & Short-Term Investments | 0.04 | 0.02 | 0.01 | 0.1 | 0 |
| Cash Growth | 61.38% | 248.58% | -93.35% | 33806.12% | - |
| Accounts Receivable | 0 | - | - | 0.36 | - |
| Other Receivables | - | - | 0.01 | 0.02 | 0 |
| Receivables | 0 | - | 0.01 | 0.37 | 0 |
| Inventory | - | - | - | 0.48 | 0.69 |
| Prepaid Expenses | 0.2 | 0.11 | - | - | - |
| Other Current Assets | 0.36 | 0.2 | 0.49 | 0.18 | 0.26 |
| Total Current Assets | 0.6 | 0.33 | 0.5 | 1.13 | 0.95 |
| Property, Plant & Equipment | 4.01 | 3.01 | 0.25 | 1.99 | 1.73 |
| Other Long-Term Assets | 0.01 | 0.01 | 1.35 | - | - |
| Total Assets | 4.62 | 3.35 | 2.1 | 3.26 | 2.83 |
| Accounts Payable | 0.28 | 0.19 | - | 1.23 | 1.09 |
| Accrued Expenses | 0.03 | 0.03 | - | 0.06 | 0.03 |
| Short-Term Debt | - | - | - | 1.56 | 1.29 |
| Current Portion of Long-Term Debt | 0.45 | - | - | - | - |
| Current Portion of Leases | 0.09 | 0.09 | 0.06 | 0.07 | 0 |
| Current Income Taxes Payable | 0.02 | 0.02 | - | 0 | 0 |
| Other Current Liabilities | 4.12 | 2.64 | 2.46 | 0.01 | - |
| Total Current Liabilities | 4.99 | 2.97 | 2.52 | 2.92 | 2.41 |
| Long-Term Debt | - | 0.43 | 0.41 | 0.41 | 0.41 |
| Long-Term Leases | 0.01 | 0.11 | 0.12 | 0.2 | 0.01 |
| Total Liabilities | 5 | 3.5 | 3.06 | 3.54 | 2.84 |
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Additional Paid-In Capital | 0.22 | 0.22 | 0.22 | - | - |
| Retained Earnings | -0.7 | -0.47 | -1.22 | -0.5 | -0.01 |
| Comprehensive Income & Other | 0.09 | 0.09 | 0.04 | 0.22 | -0.01 |
| Shareholders' Equity | -0.38 | -0.15 | -0.95 | -0.28 | -0.01 |
| Total Liabilities & Equity | 4.62 | 3.35 | 2.1 | 3.26 | 2.83 |
| Total Debt | 0.55 | 0.63 | 0.59 | 2.24 | 1.72 |
| Net Cash (Debt) | -0.51 | -0.6 | -0.59 | -2.14 | -1.72 |
| Net Cash Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Filing Date Shares Outstanding | 111.12 | 111.12 | 111.12 | 111.12 | 111.12 |
| Total Common Shares Outstanding | 111.12 | 111.12 | 111.12 | 100 | 100 |
| Working Capital | -4.39 | -2.64 | -2.02 | -1.79 | -1.46 |
| Book Value Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
| Tangible Book Value | -0.38 | -0.15 | -0.95 | -0.28 | -0.01 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
| Buildings | - | - | - | 0.69 | 0.67 |
| Machinery | 0.11 | 0.16 | 0.1 | 1.21 | 1.07 |
Source: S&P Capital IQ. Standard template. Financial Sources.